Product Reports Resources Pricing Login Book a demo

Hatteras Venture Partners

Venture Capital · Founded 2000 · Durham, United States

#1,250 Investor rankamong investors on Dealroom

Venture capital firm that builds transformational companies in the areas of biopharmaceuticals, medical devices, diagnostics, healthcare IT, and related opportunities in human medicine

Website ↗LinkedIn ↗
65 Portfolio companies+38% in 5 years
1 Unicorns
107 Investments
Jul 2026 Last investment
01 · Fund commitments

The funds Hatteras Venture Partners backs.

Hatteras Venture Partners is a limited partner in 2 funds.

HBM Healthcare Investments
Switzerland
HBM Partners
Switzerland
02 · Knowledge graph
News RapidPulse raises $48M Series B with Medtronic backing for stroke tech Jul 16, 2026 News CREATE Medicines raises $122M to advance in vivo CAR therapy May 14, 2026
03 · Portfolio analysis

Where Hatteras Venture Partners’ portfolio is concentrated.

Distribution of portfolio companies by headquarters country, sector, entry stage and current growth stage. Across all 65 portfolio companies. "Stage entered" is the first priced round the investor joined, derived from the investor’s transaction history.

By countryCount
  1. USA66
  2. Canada1
  3. UK1
By sectorCount
  1. Health60
  2. Enterprise Software2
  3. Fintech2
  4. Kids2
  5. Media2
  6. Wellness Beauty2
  7. Event Tech1
  8. Robotics1
By stage enteredCount
  1. Series A37
  2. Series B+19
  3. Seed9
By growth stageCount
  1. Breakout Stage39
  2. Early Growth16
  3. Late Growth13
04 · Portfolio market map

Inside Hatteras Venture Partners’ portfolio.

The 60 highest-funded portfolio companies, of 65 tracked.

HistoSonics
Health · Unicorn
$3.8B
CVRx
Health
$58M
Shattuck Labs
Health
$607M
Caidya
Health
$200M
CREATE Medicines
Health
$488M
Atsena Therapeutics
Health
$600M
Elligo Health Research
Health
$540M
Endogenex
Health
$440M
Vig­il Neu­ro­science
Health
$321M
PhaseBio Pharmaceuticals
Health
$740K
GrayBug
Health
$9.5M
Mercy BioAnalytics
Health
$236M
Viamet Pharmaceuticals
Health
$48M
StrideBio
Health
$326M
G1 Therapeutics
Health
$364M
AN2 Therapeutics
Health
$128M
Code Biotherapeutics
Health
$300M
ORIG3N
Health
$105M
Incyclix Bio
Health
$150M
RapidPulse
Health
$192M
Contego Medical
Health
$110M
Qpex Biopharma
Health
$132M
AtaCor Medical
Health
$112M
Trefoil Therapeutics
Health
$112M
Rodin Therapeutics
Health
$108M
Aer Therapeutics
Health
$20M
Sensorium Therapeutics
Health
$150M
Clearside Biomedical
Health
GeneCentric Therapeutics
Health
$32M
410 Medical
Health
$56M
Qvella Corporation
Health
$100M
Veralox Therapeutics
Health
$96M
Ribometrix
Health
$31M
Standard Bariatrics
Health
$175M
Artizan Biosciences
Health
$76M
Belhaven Bio
Health
$129M
Wildflower Health
Health
$104M
Boomerang Medical
Health
$80M
Sideris Pharmaceuticals
Health
$128M
iVEAcare
Health
$110M
GoCheck (Gobiquity, Inc.)
Health
$40M
Pharaoh Neuro
Health
$80M
Boragen
Health
$8.0M
Spyryx Biosciences
Health
Nusirt
Health
$8.0M
Ten63 Therapeutics
Health
$64M
BEKHealth
Health
$28M
Cardiosense
Health
$60M
Clinverse
Fintech
$36M
BITT
Health
$40M
Huma.ai
Health
Panaceutics Nutrition
Robotics
$38M
Jumo Health
Wellness Beauty
$23M
Altis Biosystems
Health
$25M
Synaptrix
Health
$40M
Perfuse Therapeutics
Health
$300M
SpineAlign Medical
Health
$35M
Seaport Diagnostics
Health
Medfusion
Health
$43M
Sign In Compliance
USA
05 · Portfolio founders

Where Hatteras Venture Partners’ portfolio founders come from.

67 founders across the 68 highest-funded portfolio companies — by current location, university attended, and the companies they worked at before founding. Sourced from the founder records the API links to each portfolio company.

LocationCount
  1. United States59
  2. United Kingdom4
  3. Belgium1
  4. Canada1
  5. India1
UniversityCount
  1. Duke University3
  2. Massachusetts Institute of Technology3
  3. Stanford University3
  4. University of Minnesota Twin Cities3
  5. University of North Carolina at Chapel Hill3
  6. University of Southern California3
  7. Yale University3
  8. Columbia University Vagelos College of Physicians and Surgeons2
  9. Fuqua School of Business, Duke University2
  10. Harvard Business School2
Previous companyCount
  1. Boston Scientific5
  2. Cameron Health3
  3. Eli Lilly2
  4. G1 Therapeutics2
  5. McKesson Surgical Solutions2
  6. Medtronic2
  7. Merck & Co.2
  8. National Institutes of Health2
  9. PneumRx2
  10. ABB1
06 · Similar investors

Similar investors.

Peers the API surfaces as most similar by portfolio shape, with Dealroom investor rank and portfolio scale.

Fidelity Investments
Private Equity · Boston
#7 rank 363 companies $6.1T portfolio
NEA
Venture Capital · Menlo Park
#36 rank 1,186 companies $2.5T portfolio
Norwest Venture Partners
Private Equity · Palo Alto
#86 rank 489 companies $387B portfolio
HTGF
Venture Capital · Bonn
#681 rank 578 companies $28B portfolio
MassChallenge
Accelerator · Boston
#10,963 rank 1,065 companies $20B portfolio
Khosla Ventures
Venture Capital · Menlo Park
#53 rank 856 companies $1.9T portfolio
Eurazeo
Private Equity · Paris
#97 rank 375 companies $159B portfolio
Canaan
Venture Capital · Menlo Park
#136 rank 402 companies $162B portfolio